MyMyelomaTeam

Teclistamab (Tecvayli) is given as a subcutaneous injection — meaning it's injected into the fatty tissue just under the skin, rather than into a vein. As for frequency, the dosing schedule typically starts with step-up doses (to help reduce the risk of reactions), then moves to weekly dosing, and may eventually shift to Show Full Answer

Teclistamab (Tecvayli) is given as a subcutaneous injection — meaning it's injected into the fatty tissue just under the skin, rather than into a vein. As for frequency, the dosing schedule typically starts with step-up doses (to help reduce the risk of reactions), then moves to weekly dosing, and may eventually shift to less frequent dosing over time. Your oncologist will tailor the exact schedule based on your response to treatment and how well you're tolerating it.

It's always worth having a detailed conversation with your care team about what the schedule will look like for your specific situation — they'll walk you through every step.

 AI-generated responses are not a substitute for medical advice. These services are not intended to diagnose, treat, or cure any condition or disease. Always ask your doctor about specific health concerns.

What Is BCMA-Targeted Immunotherapy? (VIDEO)

FDA-Approved Drug Combo Lowers Myeloma Progression Risk by 83%